$OXBR
Oxbridge Re Holdings Ltd Stock $oxbr

$oxbr Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000165495422006595 Filed on May 12, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$0.00	$2.272M	$319.0K
YoY Change	-100.0%	632.9%	6.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$338.0K	$460.0K	$250.0K
YoY Change	35.2%	76.92%	0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.000K	$1.000K	$3.000K
YoY Change	-33.33%
% of Gross Profit
Operating Expenses	$361.0K	$508.0K	$272.0K
YoY Change	32.72%	63.87%	-20.0%
Operating Profit
YoY Change
Interest Expense	-$20.00K	-$201.0K	$120.0K
YoY Change	-116.67%	-205.79%	-136.36%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$361.0K	$1.563M	$47.00K
YoY Change	-868.09%	768.33%	-113.06%
Income Tax	$26.00K
% Of Pretax Income
Net Earnings	-$387.0K	$1.563M	$28.00K
YoY Change	-1482.14%	768.33%	-107.69%
Net Earnings / Revenue		68.79%	8.78%
Basic Earnings Per Share	-$0.07		$0.00
Diluted Earnings Per Share	-$0.07	$272.2K	$0.00
COMMON SHARES
Basic Shares Outstanding	5.751M shares	5.734M shares	5.734M shares
Diluted Shares Outstanding	5.751M shares		5.734M shares

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$5.148M	$5.418M	$6.763M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$35.00K	$5.000K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$8.000K	$9.000K	$210.0K
YoY Change	-96.19%	-30.77%	-27.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$11.71M	$11.75M	$1.560M
YoY Change	650.51%	1387.34%	60.82%
Other Assets	$2.172M	$1.891M	$4.800M
YoY Change	-54.75%	-0.99%	105.13%
Total Long-Term Assets	$17.12M	$17.68M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$35.00K	$5.000K
Total Long-Term Assets	$17.12M	$17.68M
Total Assets	$17.15M	$17.69M	$8.810M
YoY Change	94.69%	94.75%	-2.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$216.0K
YoY Change
Accrued Expenses	$113.0K	$135.0K	$200.0K
YoY Change	-43.5%	-38.64%	-28.57%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$500.0K	$472.0K	$410.0K
YoY Change	21.95%	9.77%	-29.31%
LONG-TERM LIABILITIES
Long-Term Debt	$216.0K	$216.0K	$220.0K
YoY Change	-1.82%	-1.82%	-63.33%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$216.0K	$216.0K	$220.0K
YoY Change	-1.82%	-1.82%	-63.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$500.0K	$472.0K	$410.0K
Total Long-Term Liabilities	$216.0K	$216.0K	$220.0K
Total Liabilities	$856.0K	$1.038M	$740.0K
YoY Change	15.68%	-1.89%	-45.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$16.10M	-$15.71M
YoY Change		-35.28%
Common Stock	$6.000K	$32.36M
YoY Change		0.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.30M	$16.65M	$8.068M
YoY Change
Total Liabilities & Shareholders Equity	$17.15M	$17.69M	$8.810M
YoY Change	94.69%	94.75%	-2.65%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	-$387.0K	$1.563M	$28.00K
YoY Change	-1482.14%	768.33%	-107.69%
Depreciation, Depletion And Amortization	$2.000K	$1.000K	$3.000K
YoY Change	-33.33%
Cash From Operating Activities	-$69.00K	-$143.0K	-$67.00K
YoY Change	2.99%	-1530.0%
INVESTING ACTIVITIES
Capital Expenditures		-$3.000K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$201.0K	$0.00	-$650.0K
YoY Change	-69.08%	-100.0%	8.33%
Cash From Investing Activities	-$201.0K	-$3.000K	-$646.0K
YoY Change	-68.89%	-103.75%	7.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-$69.00K	-143.0K	-$67.00K
Cash From Investing Activities	-$201.0K	-3.000K	-$646.0K
Cash From Financing Activities		0.000
Net Change In Cash	-$270.0K	-146.0K	-$713.0K
YoY Change	-62.13%	-262.22%	18.83%
FREE CASH FLOW
Cash From Operating Activities	-$69.00K	-$143.0K	-$67.00K
Capital Expenditures		-$3.000K	$0.00
Free Cash Flow	-$69.00K	-$140.0K	-$67.00K
YoY Change	2.99%	-1500.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Investments Investments	10943000	USD
CY2021Q4	us-gaap	Investments Investments	11173000	USD
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5781587	shares
CY2022Q1	oxbr	Equity Securities Cost Basis EquitySecuritiesCostBasis	1730000	USD
CY2021Q4	oxbr	Equity Securities Cost Basis EquitySecuritiesCostBasis	1522000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	765000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	577000	USD
CY2022Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2976000	USD
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	3527000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2172000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1891000	USD
CY2022Q1	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	4000	USD
CY2021Q4	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	284000	USD
CY2022Q1	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	35000	USD
CY2021Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	5000	USD
CY2022Q1	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	15000	USD
CY2021Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	38000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	112000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	135000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	122000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	50000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9000	USD
CY2022Q1	us-gaap	Assets Assets	17152000	USD
CY2021Q4	us-gaap	Assets Assets	17689000	USD
CY2022Q1	us-gaap	Notes Payable NotesPayable	216000	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	216000	USD
CY2022Q1	us-gaap	Unearned Premiums UnearnedPremiums	140000	USD
CY2021Q4	us-gaap	Unearned Premiums UnearnedPremiums	350000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	135000	USD
CY2022Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	387000	USD
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	337000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	856000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	1038000	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5781587	shares
CY2022Q1	oxbr	Ordinary Shares Outstanding OrdinarySharesOutstanding	5749587	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32387000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32355000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16097000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15710000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	16296000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16651000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17152000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17689000	USD
CY2022Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	210000	USD
CY2021Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	181000	USD
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	33000	USD
CY2021Q1	us-gaap	Net Investment Income NetInvestmentIncome	14000	USD
CY2022Q1	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	7000	USD
CY2021Q1	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-230000	USD
CY2021Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-20000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	124000	USD
CY2022Q1	us-gaap	Revenues Revenues	0	USD
CY2021Q1	us-gaap	Revenues Revenues	319000	USD
CY2022Q1	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	23000	USD
CY2021Q1	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	20000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	338000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	252000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	361000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	272000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-361000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	47000	USD
CY2022Q1	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-26000	USD
CY2021Q1	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-19000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-387000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	28000	USD
CY2022Q1	oxbr	Basic And Diluted Earning Per Share BasicAndDilutedEarningPerShare	-0.07
CY2021Q1	oxbr	Basic And Diluted Earning Per Share BasicAndDilutedEarningPerShare	0.00
CY2022Q1	oxbr	Basic And Diluted BasicAndDiluted	5751008000	shares
CY2021Q1	oxbr	Basic And Diluted BasicAndDiluted	5733587000	shares
CY2022Q1	us-gaap	Profit Loss ProfitLoss	387000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-28000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	32000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	15000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	2000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	3000	USD
CY2022Q1	oxbr	Net Realized Investment Gains NetRealizedInvestmentGains	7000	USD
CY2021Q1	oxbr	Net Realized Investment Gains NetRealizedInvestmentGains	0	USD
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-230000	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2022Q1	oxbr	Equity Securities Fair Value Net Unrealized Gain Loss EquitySecuritiesFairValueNetUnrealizedGainLoss	-20000	USD
CY2021Q1	oxbr	Equity Securities Fair Value Net Unrealized Gain Loss EquitySecuritiesFairValueNetUnrealizedGainLoss	124000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	0	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2000	USD
CY2022Q1	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	-280000	USD
CY2021Q1	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	-326000	USD
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-30000	USD
CY2021Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	USD
CY2022Q1	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-23000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-32000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	72000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	53000	USD
CY2022Q1	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-210000	USD
CY2021Q1	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-291000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	50000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-1000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-69000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-67000	USD
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	409000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	648000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	208000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	2000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-201000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-646000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-270000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-713000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5418000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7476000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5148000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6763000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	8025000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	28000	USD
CY2021Q1	oxbr	Share Based Compensation Expense ShareBasedCompensationExpense	15000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	8068000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16651000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-387000	USD
CY2022Q1	oxbr	Share Based Compensation Expense ShareBasedCompensationExpense	32000	USD
CY2022Q1	oxbr	Issuance Of Restricted Stock Amount IssuanceOfRestrictedStockAmount	0	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	16296000	USD
CY2022Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;"><strong><span style="text-decoration:underline">Reclassifications:</span></strong> Any reclassifications of prior period amounts have been made to conform to the current period presentation.</p>
CY2022Q1	us-gaap	Due From Banks DueFromBanks	2691000	USD
CY2021Q4	us-gaap	Due From Banks DueFromBanks	2977000	USD
CY2022Q1	oxbr	Cash Held With Custodians CashHeldWithCustodians	285000	USD
CY2021Q4	oxbr	Cash Held With Custodians CashHeldWithCustodians	550000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2172000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1891000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	5148000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	5418000	USD
CY2021Q3	oxbr	Ordinary Shares OrdinaryShares	1500000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3094999	shares
CY2021Q3	oxbr	Aggregate Purchase Price AggregatePurchasePrice	2000000	USD
CY2021Q3	oxbr	Capital Risk Percentage CapitalRiskPercentage	0.347	pure
CY2021Q3	oxbr	Ordinary Shares Percentage OrdinarySharesPercentage	0.496	pure
CY2021Q3	oxbr	Preferred Shares Percentage PreferredSharesPercentage	0.631	pure
CY2022Q1	oxbr	Unrealized Gain On Investments In Affiliate UnrealizedGainOnInvestmentsInAffiliate	230000	USD
CY2022Q1	us-gaap	Long Term Investments LongTermInvestments	10943000	USD
CY2022Q1	oxbr	Long Term Investments Beginning LongTermInvestmentsBeginning	11173000	USD
CY2022Q1	oxbr	Unrealized Loss On Other Investment UnrealizedLossOnOtherInvestment	-230000	USD
CY2022Q1	oxbr	Long Term Investments End LongTermInvestmentsEnd	10943000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2976000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2172000	USD
CY2022Q1	us-gaap	Long Term Investments LongTermInvestments	10943000	USD
CY2022Q1	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	765000	USD
CY2022Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	16856000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	3527000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1891000	USD
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	11173000	USD
CY2021Q4	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	577000	USD
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	17168000	USD
CY2022Q1	oxbr	Fair Value Measurements Inputs For Private Placement Warrants Tabletextblock FairValueMeasurementsInputsForPrivatePlacementWarrantsTabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>At March 31,</strong></p><p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>At December 31,</strong></p><p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9.90</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">24</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">24.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.06</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.54</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected life (in years)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.67</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.98</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	216000	USD
CY2022Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-06-01
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-387000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	28000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5751008	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5733587	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5751008	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5733587	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8230700	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8230700	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	8230700	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.50
CY2022Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	9.38
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	540000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.86
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y4M24D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	400000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.00
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	940000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.77
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M12D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	438125	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.52
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y10M24D
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	896250	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.71
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M24D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	896250	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.71
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M6D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	601250	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.44
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y8M12D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	98000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	166000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P23Y
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	400000	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	43750	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	44000	shares
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	244000	USD
CY2022Q1	oxbr	Statutory Accounting Practice Statutory Capital And Surplus Required StatutoryAccountingPracticeStatutoryCapitalAndSurplusRequired	Under the terms of their respective licenses, Oxbridge Reinsurance Limited and Oxbridge Re NS are required to maintain a minimum and prescribed capital requirement of $500 in accordance with the relevant subsidiary’s approved business plan filed with CIMA
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	24000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	24000	USD
CY2022Q1	oxbr	Cash Paid Amounts Included In Measurement Of Lease Liabilities Operating Cash Flows Operating Leases CashPaidAmountsIncludedInMeasurementOfLeaseLiabilitiesOperatingCashFlowsOperatingLeases	24000	USD
CY2021Q1	oxbr	Cash Paid Amounts Included In Measurement Of Lease Liabilities Operating Cash Flows Operating Leases CashPaidAmountsIncludedInMeasurementOfLeaseLiabilitiesOperatingCashFlowsOperatingLeases	24000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	112000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	135000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	113000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	135000	USD
CY2022Q1	oxbr	Weighted Average Remaining Lease Term Operating Leases WeightedAverageRemainingLeaseTermOperatingLeases	P1Y5M23D
CY2021	oxbr	Weighted Average Remaining Lease Term Operating Leases WeightedAverageRemainingLeaseTermOperatingLeases	P1Y8M4D
CY2022Q1	oxbr	Weighted Average Discount Rate Operating Leases WeightedAverageDiscountRateOperatingLeases	0.0560	pure
CY2021	oxbr	Weighted Average Discount Rate Operating Leases WeightedAverageDiscountRateOperatingLeases	0.0549	pure
CY2022Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	73000	USD
CY2021Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	97000	USD
CY2021Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	40000	USD
CY2022Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	40000	USD
CY2021Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	6000	USD
CY2022Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	6000	USD
CY2022Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	119000	USD
CY2021Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	143000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	8000	USD
CY2021Q1	oxbr	Total Operating Lease Liability TotalOperatingLeaseLiability	135000	USD

Files In Submission

Name	View Source	Status
0001654954-22-006595-index-headers.html	Edgar Link	pending
0001654954-22-006595-index.html	Edgar Link	pending
0001654954-22-006595.txt	Edgar Link	pending
0001654954-22-006595-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oxbr-20220331.xsd	Edgar Link	pending
oxbr-20220331_cal.xml	Edgar Link	unprocessable
oxbr-20220331_def.xml	Edgar Link	unprocessable
oxbr-20220331_lab.xml	Edgar Link	unprocessable
oxbr-20220331_pre.xml	Edgar Link	unprocessable
oxbr_10q.htm	Edgar Link	pending
oxbr_10q_htm.xml	Edgar Link	completed
oxbr_ex311.htm	Edgar Link	pending
oxbr_ex312.htm	Edgar Link	pending
oxbr_ex32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OXBR
Oxbridge Re Holdings Ltd Stock $oxbr

2022 Q1 Form 10-Q Financial Statement

#000165495422006595 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OXBR Oxbridge Re Holdings Ltd Stock $oxbr

2022 Q1 Form 10-Q Financial Statement

#000165495422006595 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OXBR
Oxbridge Re Holdings Ltd Stock $oxbr